Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone vs Micronized Progesterone in Threatened Miscarriage
NCT05542797Phase 4Unknown
- Sponsor
- Konya Meram State Hospital
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of dydrogesterone, progesterone in threatened miscarriage, sponsored by Konya Meram State Hospital. Status: unknown.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
threatened miscarriage
Beyond the preview
Go deeper on NCT05542797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05542797.